Vanguard is proud to host the biggest names in remediation science for #3 in our extraction webinar series. The term Remediation is the “BuzzWord de Jour” of the global CBD oil industry, however, arriving at a common and useful understanding of the process is easier said than done.
On Wednesday, October 14th, Vanguard Scientific hosted webinar #3 in our 2020 series on extraction compliance and technology. The series, primarily focused on helping processors to prepare for federal regulation and/or international export, looks at everything from product formulation and production to lab design and facility construction, with the 10/14 session dedicated entirely to the rapidly evolving conversation around THC remediation.
Joined by another heavyweight panel, Vanguard Scientific CEO Matthew Anderson and co-host, Vanguard SVP of Technology Integration Chris Chappie, unpacked key concepts in Remediation from definitions and buyer-specific requirements, to an exploration of the current methods of cannabinoid separation. With guests Dr. John MacKay and Chase McMichaels, Matthew and Chris walked the audience through the science (and pseudo-science) driving developments (and controversy) throughout the industry, as well as an illuminating review of the unit economics and recommended uses for superfluid chromatography and harmonic distillation; the leading methods for getting to THC-Free oil.
Webinar Highlights Include:
- Definitions of Remediation and its subcategories: THC Removal, Conversion, and Separation
- Breaking down the differences in different types of cannabis oil: Broad Spectrum, Full Spectrum, Isolate, Distillate, Acids, Isomers and other minor cannabinoids or terpenes
- Descriptions of THC-Free variants: THC Compliant (US and Abroad), THC Free
- Retrospective look at the evolution (and inherent challenges) of THC remediation
- Unpacking the costs, compliance, and process bottlenecks faced by processors
- Dissection of buyer personas: Pharma, Cosmetics, CPG, Nutritional Supplements
- Examination of remediation technologies (and where they’re most effective): Harmonic Distillation, Flash Chromatography, Superfluid Chromatography
- Disassemble the rumor mill: Remediation (pseudo) science: Carcinogens from Cannabis? Where does the THC go?
- Take audience questions for our expert panel
More About Our Expert Panel
Matthew is dedicated to spiritual science and the belief plant-based medicines can truly heal. As Co-Founder/CEO of Vanguard Scientific Systems, one of the world’s leading providers of end-to-end solutions for integrated botanical extraction and purification equipment and services, Matthew is uniquely positioned to change how the world’s leading processing, extraction, and active-ingredient manufacturers work with cannabis, hemp, and other natural botanicals.
Matthew intends to deliver a global network of integrated systems and solutions to meet the processing needs of the rapidly evolving cannabis and hemp industries. Through partnerships committed to market-leading technology, standards, quality control, and training excellence, Vanguard Scientific Systems will lead with compliance and consistency to provide a stable supply chain to the global marketplace.
Anderson received his degrees in International Business and Economics from Rollins College with an area focus in Performance Ensemble.
Matt is a familiar face in the media and on stages around the world, where he's regularly tapped for insights on the fast-changing cannabis landscape. You may have seen him on The Green Rush, New Cannabis Ventures, CFN, The Motley Fool, Forbes, and News24.
Chris Chappie has been in the cannabis industry for more than 20 years.
Having worked in hydroponics, CO2 extractions, hydrocarbon extractions, ethanol extraction, and branding, Chris brings a wealth of experience to the Vanguard team.
Currently his role as SVP of Systems Integration well suits his experience in building functioning labs that are purposefully designed for bringing products to market. His seat as Chairman of Vanguard's Science and Technology Review Board allows Chris, and Vanguard, the opportunity to keep tabs on the best new equipment entering the market. This allows Vanguard to maintain their stance of being "technology agnostic" and offers clients the assurance that the equipment they get is "best in class".
Chris' vast experience and expertise brings a unique and educated point of view to the panel.
Chase McMichael brings over 20 years of material engineering, automation, and data science currently focused on cannabinoid creation. At PWM, Chase led the team in discovering cannabinoid modulation utilizing Supercritical CO2 extraction methods. He is responsible for the optimized PWM “Sweet Crude” as well as advancing distillation and large scale remediation refinement. Chase’s work at PWM has led to the US patent filing of CBGA extraction process “In-situ custom cannabinoid formulation”.
As the former CSO of a cannabinoid testing platform and a partner with Agilent Technologies, Chase built the product, software, and science team to deploy the first cloud base HPLC data analytic for the hemp industry. Chase’s chemical engineering background coupled with data analysis has led to utilizing machine learning over large data sets to further improve accuracy in material process monitoring.
Chase has a long track record scaling deployments for F500 companies to several silicon valley startups with an extensive operational background. At the University of Houston, Chase worked for the renowned House Science Center in the field of material modification using ion implantation in polymers as well as developing superconducting materials. Chase has published several technical papers, US patents and graduated with BS in Physics and a minor in Math/Chemistry.
John MacKay, PhD
Dr. John MacKay is an internationally recognized scientific expert in analytical testing, extraction and purification techniques within the botanical space. His career has included many roles in innovative product development. Dr. MacKay is currently a contributing journalist of Extraction Magazine, a cannabis extraction publication, and Terpenes and Testing Magazine, a publication serving the cannabis industry with cannabis news and science on horticulture, extraction and testing labs. Dr. MacKay earned his B.A. in Chemistry from St. Lawrence University and his Ph.D. from the University of Vermont in Inorganic Chemistry focused on the synthesis of cancer fighting compounds.